BioTek reMEDys taps TJM Labs to automate benefits verification

BioTek reMEDys has selected TJM Labs to automate insurance eligibility and benefits verification across specialty pharmacy workflows, including outbound payer calls. The rollout is designed to speed patient access to complex therapies while reducing manual work for pharmacy teams.

Why it matters: - Specialty pharmacies rely on fast, accurate benefits verification to get patients access to high-cost therapies. - Automating document handling and payer calls can reduce manual work, improve data quality and shorten delays in care. - The shift matters most for patients with rare diseases and chronic conditions, where coverage checks can slow treatment start times.

What happened: - BioTek reMEDys selected TJM Labs to automate insurance eligibility and benefits verification workflows. - The deployment starts with incoming patient documentation and creation of patient profiles inside BioTek reMEDys' pharmacy management system. - TJM Labs Voice AI is also being used for outbound phone calls to payers for benefits verification. - TJM Labs said its AI agents are already processing more than 4,500 patient records per week for BioTek reMEDys.

The details: - BioTek reMEDys is a specialty pharmacy and integrated infusion therapy provider serving patients with rare diseases and chronic conditions. - The company handles complex therapies including biologics and biotherapeutics. - Its verification workflow includes reviewing thousands of incoming documents, updating patient profiles, verifying insurance information and contacting payers by phone. - The Voice AI system is designed to automate calls that verify patient eligibility and benefits. - TJM Labs said the goal is to improve the speed and consistency of benefits data collection while giving BioTek reMEDys more control over the verification process. - TJM Labs' platform also automates prescription intake, data entry, prior authorization support, patient communication and other operational tasks. - The platform works inside existing pharmacy systems rather than replacing them.

Between the lines: - The deal points to a broader use case for AI agents in specialty pharmacy, where workflows are more customized than standard prescription processing. - TJM Labs is positioning its platform as a way to automate multi-step tasks across documents, pharmacy systems and payer interactions in both digital and voice channels. - BioTek reMEDys is using automation to keep staff focused on patient care instead of repetitive administrative work.

What's next: - BioTek reMEDys is continuing to expand TJM Labs across its verification workflow. - The companies are likely to use the early record-processing rollout as the base for broader automation across additional pharmacy operations. - TJM Labs said its broader platform is built to help pharmacies scale operational work without replacing existing technology.

The bottom line: - BioTek reMEDys is betting on AI agents to make a slow, labor-heavy part of specialty pharmacy faster and more consistent, especially where payer verification directly affects patient access.